Stock ownership · SEC 13F · Q3 2025
VERONA PHARMA PLC
Institutional ownership of VERONA PHARMA PLC (CUSIP 925050106) - who holds it, how concentrated it is, and what moved last quarter.
- $12.7M
- Reported value
- 6
- Institutions
- 100%
- Top-5 share
The verdict
According to SEC Form 13F-HR filings in this corpus, VERONA PHARMA PLC ranks #401 of 775 tracked securities by reported institutional value (largest first), matching the /stocks listing among names with ≥5 reporting holders. 6 institutions report $12.7M as of Q3 2025, with ownership heavily concentrated in a handful of holders.
- 6
- institutions hold it
- $12.7M
- reported 13F value
- 100%
- held by top 5
- #401
- of 775 by value
Based on long positions reported to the SEC as of Q3 2025; 13F omits shorts, options and non-US holdings.
According to SEC Form 13F-HR filings in this corpus, VERONA PHARMA PLC ranks #401 of 775 tracked securities by reported institutional value (largest first), matching the /stocks listing among names with ≥5 reporting holders.
How 13F ownership is computed · All tracked stocks · Concentration rankings
SEC Form 13F-HR ownership desk
CUSIP 925050106 · Q3 2025 $13M reported
VALUE-LIGHT · HOLDERS-FOCUS · CONC-DOM · PHOTO-FINISH · ACTIVITY-MID · BOOK-MID
- VALUE-LIGHT #401/775
- HOLDERS-FOCUS 6 filers
- CONC-DOM 100% top-5
- PHOTO-FINISH BERKSHIRE HATHAWAY DEL
- ACTIVITY-MID 6 new
- BOOK-MID 5Q history
Photo-finish peer on reported value: BERKSHIRE HATHAWAY INC DEL
Read with: Ownership concentration guide - VERONA PHARMA PLC's top-five holders account for 100% of reported value — read concentration before treating any single filer as a signal.
Reported-value neighbourhood · VERONA PHARMA PLC
Nearest tracked securities by aggregate 13F reported value, not a full corpus reprint.
Institutional ownership over time
The number of institutions reporting a VERONA PHARMA PLC position has risen from 1 to 6 over the last 5 quarters of 13F filings.
Top Institutional Holders
| # | Institution | Shares | Value | Share of reported |
|---|---|---|---|---|
| 1 | Maven Securities LTD | 80,000 | $8.5M | 67.2% |
| 2 | Alpine Global Management, LLC | 30,000 | $3.2M | 25.2% |
| 3 | EQUITEC PROPRIETARY MARKETS, LLC | 8,200 | $875K | 6.9% |
| 4 | JPMORGAN CHASE & CO (JPM, AMJB, VYLD, JPM-PC, JPM-PD, JPM-PJ, JPM-PK, JPM-PL, JPM-PM) | 512 | $55K | 0.4% |
| 5 | CIBC Private Wealth Group LLC | 375 | $40K | 0.3% |
| 6 | Bell Investment Advisors, Inc | 44 | $5K | 0.0% |
Investment Discretion
SEC Form 13F requires each institutional filer to report whether it exercises sole or shared discretion over a position. Among VERONA PHARMA PLC's reported holders for Q3 2025, by reported value:
Latest Quarter Activity · Q3 2025
New positions (6)
Complete exits (3)
Frequently Asked Questions
How many institutions hold VERONA PHARMA PLC?▼
Where does VERONA PHARMA PLC sit among tracked securities?▼
What is the total institutional value of VERONA PHARMA PLC?▼
How concentrated is ownership of VERONA PHARMA PLC?▼
Who is the largest institutional holder of VERONA PHARMA PLC?▼
Nationwide stocks with similar institutional value or holder count
Two 13F-derived peer sets for VERONA PHARMA PLC: nearest aggregate reported value and nearest institutional holder count, not catalog browse links.
Similar reported value
Nearest stocks by aggregate 13F reported value ($12.7M here).
Similar holder count
Nearest stocks by number of disclosing 13F holders (6 here).
Source: U.S. Securities and Exchange Commission (SEC) - EDGAR Form 13F-HR institutional holdings filings · Q3 2025 13F-HR discloses long US-listed equity positions of managers with $100M+ qualifying assets, filed within 45 days of period end. Short positions and most derivatives are not disclosed.
PlainFundData is rendered directly from SEC EDGAR Form 13F-HR institutional holdings filings, no number is typed in by an editor. Holder lists, concentration, and reported value on this page are aggregated live from those 13F-HR extracts. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-05-16.